Saba Capital Management, L.P. sold HQL

September 2, 2025 · Form 4 insider transaction

Saba Capital Management, L.P. sold 14,083 shares of Abrdn Life Sciences Investors at $14.04 per share, a transaction worth $197.7K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 2 days after the transaction.